Randomized phase 3 trial of ibrutinib/rituximab vs placebo/rituximab in Waldenström's macroglobulinemia.

Meletios A. Dimopoulos; Alessandra Tedeschi; Judith Trotman; Ramón Garcia-Sanz; David MacDonald; Veronique Leblond; Beatrice Mahe; Charles Herbaux; Constantine Tam; Maria Lia Palomba; Jeffrey Matous; Chaim Shustik; Efstathios Kastritis; Steven P. Treon; Jianling Li; Zeena Salman; Thorsten Graef; Christian Buske

doi:10.1200/JCO.2018.36.15_SUPPL.8003

Randomized phase 3 trial of ibrutinib/rituximab vs placebo/rituximab in Waldenström's macroglobulinemia.

Meletios A. Dimopoulos
, Alessandra Tedeschi
, Judith Trotman
, Ramón Garcia-Sanz
, David MacDonald
, Veronique Leblond
, Beatrice Mahe
, Charles Herbaux
, Constantine Tam
, Maria Lia Palomba
, Jeffrey Matous
, Chaim Shustik
, Efstathios Kastritis
, Steven P. Treon
, Jianling Li
, Zeena Salman
, Thorsten Graef
, Christian Buske

National and Kapodistrian University of Athens
ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy;
University of Sydney
Hospital Universitario de Salamanca, Salamanca, Spain;
University of Ottawa
University of Paris
Centre Hospitalier Universitaire de Nantes, Nantes, France;
Centre Hospitalier Régional Universitaire de Lille, Institute of Hematolog-Tranfusion, Lille, France;
Peter MacCallum Cancer Centre
Memorial Sloan-Kettering Cancer Center
Colorado Blood Institute, Denver, CO;
McGill University Health Centre
Harvard University
Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA;
University of Ulm

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
Volume	36
DOIs	https://doi.org/10.1200/JCO.2018.36.15_SUPPL.8003
State	Published - Jun 1 2018
Externally published	Yes

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1200/JCO.2018.36.15_SUPPL.8003License: Unspecified

Cite this

Dimopoulos, M. A., Tedeschi, A., Trotman, J., Garcia-Sanz, R., MacDonald, D., Leblond, V., Mahe, B., Herbaux, C., Tam, C., Palomba, M. L., Matous, J., Shustik, C., Kastritis, E., Treon, S. P., Li, J., Salman, Z., Graef, T., & Buske, C. (2018). Randomized phase 3 trial of ibrutinib/rituximab vs placebo/rituximab in Waldenström's macroglobulinemia. Journal of Clinical Oncology, 36. https://doi.org/10.1200/JCO.2018.36.15_SUPPL.8003

Dimopoulos, MA, Tedeschi, A, Trotman, J, Garcia-Sanz, R, MacDonald, D, Leblond, V, Mahe, B, Herbaux, C, Tam, C, Palomba, ML, Matous, J, Shustik, C, Kastritis, E, Treon, SP, Li, J, Salman, Z, Graef, T & Buske, C 2018, 'Randomized phase 3 trial of ibrutinib/rituximab vs placebo/rituximab in Waldenström's macroglobulinemia.', Journal of Clinical Oncology, vol. 36. https://doi.org/10.1200/JCO.2018.36.15_SUPPL.8003

@article{f9213aaab79448b4b3d4f142e319c2a5,

title = "Randomized phase 3 trial of ibrutinib/rituximab vs placebo/rituximab in Waldenstr{\"o}m's macroglobulinemia.",

author = "Dimopoulos, \{Meletios A.\} and Alessandra Tedeschi and Judith Trotman and Ram{\'o}n Garcia-Sanz and David MacDonald and Veronique Leblond and Beatrice Mahe and Charles Herbaux and Constantine Tam and Palomba, \{Maria Lia\} and Jeffrey Matous and Chaim Shustik and Efstathios Kastritis and Treon, \{Steven P.\} and Jianling Li and Zeena Salman and Thorsten Graef and Christian Buske",

year = "2018",

month = jun,

day = "1",

doi = "10.1200/JCO.2018.36.15\_SUPPL.8003",

language = "American English",

volume = "36",

journal = "Journal of Clinical Oncology",

}

TY - JOUR

T1 - Randomized phase 3 trial of ibrutinib/rituximab vs placebo/rituximab in Waldenström's macroglobulinemia.

AU - Dimopoulos, Meletios A.

AU - Tedeschi, Alessandra

AU - Trotman, Judith

AU - Garcia-Sanz, Ramón

AU - MacDonald, David

AU - Leblond, Veronique

AU - Mahe, Beatrice

AU - Herbaux, Charles

AU - Tam, Constantine

AU - Palomba, Maria Lia

AU - Matous, Jeffrey

AU - Shustik, Chaim

AU - Kastritis, Efstathios

AU - Treon, Steven P.

AU - Li, Jianling

AU - Salman, Zeena

AU - Graef, Thorsten

AU - Buske, Christian

PY - 2018/6/1

Y1 - 2018/6/1

UR - https://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.8003

U2 - 10.1200/JCO.2018.36.15_SUPPL.8003

DO - 10.1200/JCO.2018.36.15_SUPPL.8003

M3 - Article

VL - 36

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Randomized phase 3 trial of ibrutinib/rituximab vs placebo/rituximab in Waldenström's macroglobulinemia.

Disciplines

Access to Document

Other files and links

Cite this